What will it take to eliminate hepatitis B as a public health threat in the United States and Canada?
Su Wang(Rutgers, The State University of New Jersey), Chari Cohen(Hepatitis B Foundation), Camilla S. Graham(Harvard University), Carla Osiowy(Public Health Agency of Canada), Amy S. Tang, Carla S Coffin(University of Calgary), Carol Jimenez(United States Department of Health and Human Services)
Cited by 3
Related Papers
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
|Clinical Infectious Diseases|2001|969
Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
|Cell stem cell|2016|565
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
|Journal of Hepatology|2019|364